OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 131 filers reported holding OCULAR THERAPEUTIX INC in Q1 2022. The put-call ratio across all filers is 1.09 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $733 | +19.4% | 233,582 | +96.4% | 0.06% | +3.3% |
Q2 2023 | $614 | -99.9% | 118,953 | -7.1% | 0.06% | -20.8% |
Q2 2022 | $514,000 | +80.4% | 127,978 | +122.1% | 0.08% | +102.6% |
Q1 2022 | $285,000 | +738.2% | 57,620 | +413.5% | 0.04% | +660.0% |
Q3 2019 | $34,000 | -66.7% | 11,222 | -28.1% | 0.01% | 0.0% |
Q1 2018 | $102,000 | -60.9% | 15,600 | +25.7% | 0.01% | -50.0% |
Q2 2015 | $261,000 | – | 12,412 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 1,932,607 | $40,643,000 | 15.56% |
Lamond Capital Partners LLC | 711,533 | $14,964,000 | 15.19% |
Polaris Venture Management Co. V, L.L.C. | 1,230,009 | $25,867,000 | 11.54% |
NOTTINGHAM ADVISORS, INC. | 171,985 | $3,617,000 | 0.60% |
Portolan Capital Management | 122,518 | $2,577,000 | 0.36% |
SPHERA FUNDS MANAGEMENT LTD. | 160,000 | $3,365,000 | 0.33% |
Rotella Capital Management, Inc. | 18,461 | $388,000 | 0.32% |
Monashee Investment Management LLC | 28,834 | $606,000 | 0.29% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 335,498 | $7,056,000 | 0.24% |
BAILARD, INC. | 55,000 | $1,157,000 | 0.18% |